gemfibrozil has been researched along with mannitol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, G; Rosaiah, JN; Sashidhara, KV; Saxena, JK | 1 |
| Bhatia, G; Khan, MM; Khanna, AK; Kumar, A; Sashidhara, KV; Saxena, JK | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bhatia, G; Ghosh, S; Khan, MM; Khanna, AK; Misra, AK | 1 |
| Bhatia, G; Kumar, A; Kumar, M; Maurya, RA; Sharma, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bhatia, G; Khanna, AK; Kumar, A; Rosaiah, JN; Sashidhara, KV | 1 |
| Bhatia, G; Khanna, AK; Kumar, A; Kumar, M; Sashidhara, KV; Sonkar, R | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bhatia, G; Chaturvedi, U; Khanna, AK; Narender, T; Rajendar, K; Sarkar, S; Singh, VK | 1 |
| Bhatia, G; Dodda, RP; Khanna, AK; Palnati, GR; Sashidhara, KV; Sonkar, R | 1 |
| Bhatia, G; Modukuri, RK; Rao, KB; Sashidhara, KV; Sonkar, R | 1 |
| Bhatia, G; Pandeti, S; Shukla, A; Sonkar, R; Tadigoppula, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bastacky, SI; Jackson, EK; Jackson, TC; McHale, T; Melhem, MF; Mi, Z; Sonalker, PA; Tofovic, SP | 1 |
1 review(s) available for gemfibrozil and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for gemfibrozil and mannitol
| Article | Year |
|---|---|
Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
Topics: Amines; Animals; Antioxidants; Coumarins; Female; Free Radicals; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Rats; Schiff Bases | 2008 |
Antidyslipidemic and antioxidative activities of 8-hydroxyquinoline derived novel keto-enamine Schiffs bases.
Topics: Amines; Animals; Antioxidants; Dyslipidemias; Fluorescence; Heparin; Hydroxyl Radical; Hydroxyquinolines; Lipid Metabolism; Male; Rats; Schiff Bases; Superoxides | 2009 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Syntheses and evaluation of glucosyl aryl thiosemicarbazide and glucosyl thiosemicarbazone derivatives as antioxidant and anti-dyslipidemic agents.
Topics: Animals; Antioxidants; Drug Evaluation, Preclinical; Dyslipidemias; Hypolipidemic Agents; Rats; Semicarbazides; Thiosemicarbazones | 2009 |
Synthesis and biological evaluation of N-aryl-1,4-dihydropyridines as novel antidyslipidemic and antioxidant agents.
Topics: Animals; Catalysis; Dihydropyridines; Free Radical Scavengers; Hypolipidemic Agents; Iodine; Lipids; Lipolysis; Male; Rats | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis of novel benzocoumarin derivatives as lipid lowering agents.
Topics: Animals; Coumarins; Hyperlipidemias; Hypolipidemic Agents; Rats; Structure-Activity Relationship | 2010 |
Novel coumarin derivatives as potential antidyslipidemic agents.
Topics: Coumarins; Dyslipidemias; Humans | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity.
Topics: Animals; Antioxidants; Hypolipidemic Agents; Male; Rats; Toluene | 2011 |
Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
Topics: Amides; Animals; Antioxidants; Enzyme Activation; Fibric Acids; Free Radicals; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Lipoprotein Lipase; Male; Polyethylene Glycols; Rats; Structure-Activity Relationship | 2012 |
Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
Topics: Animals; Antioxidants; Benzofurans; Cholesterol; Enzyme Activation; Hypolipidemic Agents; Indoles; Lipolysis; Male; Molecular Structure; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipids; Rats; Triglycerides | 2013 |
Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Topics: Animals; Antioxidants; Disease Models, Animal; Diterpenes; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Molecular Structure; Oxidation-Reduction; Rats; Rats, Inbred Strains | 2013 |
PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol.
Topics: Animals; Apoptosis; Blotting, Western; Drug Interactions; Gemfibrozil; In Vitro Techniques; Kidney; Male; Mannitol; Microscopy, Electron; Organ Preservation; Perfusion; PPAR alpha; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2007 |